Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New ways of treating Alzheimer’s

01.11.2011
Several potential drugs for the treatment of Alzheimer’s have worked well on mice – but none of them on humans. A leading researcher from the Sahlgrenska Academy at the University of Gothenburg, Sweden, is now launching brand new methods for diagnosing Alzheimer’s and monitoring treatment.
Research advances in recent years have given us a detailed knowledge of the molecular mechanisms behind Alzheimer’s disease. The spotlight has fallen on beta amyloid, a peptide formed from a special protein in the brain. The prevailing hypothesis is that the protein clumps together into plaques, which damage the brain’s nerve cells and causes the characteristic symptoms of Alzheimer’s.

The amyloid theory has spawned a large number of potential drugs which attempt to delay the development of the disease by slowing down the formation of, or even clearing, plaques. However, several major clinical trials have shown that this type of medication is not at all effective.

Kaj Blennow, a professor at the University of Gothenburg’s Sahlgrenska Academy and one of the world’s leading dementia researchers, is now taking research into new Alzheimer’s medication in a brand new direction.
“It’s important that we constantly question research results, including in Alzheimer’s research,” says Blennow. “And to do this we have to come up with new analytical methods.”

Blennow and his research colleagues believe that the solution lies in being able to test different drugs directly on living patients instead of on mice as has been the case to date.
“The mouse models currently being used have a very tenuous link to the most common form of Alzheimer’s,” says Blennow. “This is particularly obvious when new drug candidates are tested on real people – we have now identified over 100 molecules that reduce the formation of plaques in mice with Alzheimer’s, but unfortunately none have led to a single drug that slows down the illness in humans.”

Blennow and his research colleagues at the Clinical Neurochemistry Laboratory are trying instead to come up with new analytical methods that use biomarkers to monitor biochemical changes in patients with Alzheimer’s. It is hoped that the biomarkers can be used both to make an accurate and early diagnosis and to establish and monitor the effects of new drugs.

“Our studies on patients with Alzheimer’s and other age-related disorders would suggest that beta-amyloid is perhaps not the direct cause of the illness, but instead the brain’s response to different types of stress,” says Blennow. “This could completely change the way we view the illness and could play a crucial role in future treatments.”

ALZHEIMER’S DISEASE
With more than 100,000 people affected in Sweden, Alzheimer’s is one of our most common diseases. Caused by changes in the brain’s nerve cells, the disease predominantly affects the memory and often leads to an early death. Alzheimer’s results in not only considerable suffering for patients and their families, but also enormous costs to society.
For more information, please contact: Kaj Blennow
Tel: +46 (0)31 343 1791, mobile: +46 (0)761 073 835
E-mail: kaj.blennow@neuro.gu.se

Helena Aaberg | idw
Further information:
http://www.gu.se

More articles from Health and Medicine:

nachricht A promising target for kidney fibrosis
21.04.2017 | Brigham and Women's Hospital

nachricht Stem cell transplants: activating signal paths may protect from graft-versus-host disease
20.04.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

Im Focus: Quantum-physical Model System

Computer-assisted methods aid Heidelberg physicists in reproducing experiment with ultracold atoms

Two researchers at Heidelberg University have developed a model system that enables a better understanding of the processes in a quantum-physical experiment...

Im Focus: Glacier bacteria’s contribution to carbon cycling

Glaciers might seem rather inhospitable environments. However, they are home to a diverse and vibrant microbial community. It’s becoming increasingly clear that they play a bigger role in the carbon cycle than previously thought.

A new study, now published in the journal Nature Geoscience, shows how microbial communities in melting glaciers contribute to the Earth’s carbon cycle, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

New quantum liquid crystals may play role in future of computers

21.04.2017 | Physics and Astronomy

A promising target for kidney fibrosis

21.04.2017 | Health and Medicine

Light rays from a supernova bent by the curvature of space-time around a galaxy

21.04.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>